Page 24 - TD-2-1

Tumor Discovery Cancer progression in PCOS

https://doi.org/10.1016/j.ygyno.2014.11.012 syndrome and breast cancer. Oncotarget, 8(41): 69520–69526.
70. Shen CC, Yang AC, Hung JH, et al., 2015, A nationwide https://doi.org/10.18632/oncotarget.17846
population-based retrospective cohort study of the risk of 82. Cooney LG, Dokras A, 2018, Beyond fertility: Polycystic ovary
uterine, ovarian and breast cancer in women with polycystic syndrome and long-term health. Fertil Steril, 110(5): 794–809.
ovary syndrome. Oncologist, 20(1): 45–49.
https://doi.org/10.1016/j.fertnstert.2018.08.021
https://doi.org/10.1634/theoncologist.2014-0311
83. Terry KL, Willett WC, Rich-Edwards JW, et al., 2006, A
71. Haoula Z, Salman M, Atiomo W, 2012, Evaluating the prospective study of infertility due to ovulatory disorders,
association between endometrial cancer and polycystic ovulation induction, and incidence of breast cancer. Arch
ovary syndrome. Hum Reprod, 27(5): 1327–1331.
Intern Med, 166(22): 2484–2489.
https://doi.org/10.1093/humrep/des042
https://doi.org/10.1001/archinte.166.22.2484
72. Fearnley EJ, Marquart L, Spurdle AB, et al., 2010, Polycystic 84. Ledger WL, 2003, Non-reproductive consequences of polycystic
ovary syndrome increases the risk of endometrial cancer in ovary syndrome. Curr Obstet Gynecol, 13(6): 350–354.
women aged less than 50 years: An Australian case-control
study. Cancer Causes Control, 21(12): 2303–2308. https://doi.org/10.1016/S0957-5847(03)00072-6
https://doi.org/10.1007/s10552-010-9658-7 85. Mravec B, Tibensky M, 2020, Increased cancer risk
in polycystic ovary syndrome: An (un) sympathetic
73. Reid BM, Permuth JB, Sellers TA, 2017, Epidemiology of connection? Med Hypotheses, 134: 109437.
ovarian cancer: A review. Cancer Biol Med, 14(1): 9–32.
https://doi.org/10.1016/j.mehy.2019.109437
https://doi.org/10.20892/j.issn.2095-3941.2016.0084
86. Shafiee MN, Chapman C, Barrett D, et al., 2013, Reviewing
74. Risch HA, 1998, Hormonal etiology of epithelial ovarian the molecular mechanisms which increase endometrial
cancer, with a hypothesis concerning the role of androgens cancer (EC) risk in women with polycystic ovarian
and progesterone. J Natl Cancer Inst, 90(23): 1774–1786.
syndrome (PCOS): Time for paradigm shift? Gynecol Oncol,
https://doi.org/10.1093/jnci/90.23.1774 131(2): 489–492.
75. Hunn J, Rodriguez GC, 2012, Ovarian cancer: Etiology, risk https://doi.org/10.1016/j.ygyno.2013.06.032
factors, and epidemiology. Clin Obstet Gynecol, 55(1), 3–23.
87. Arcidiacono B, Iiritano S, Nocera A, et al., 2012, Insulin
https://doi.org/10.1097/GRF.0b013e31824b4611 resistance and cancer risk: An overview of the pathogenetic
mechanisms. Exp Diabetes Res, 2012: 789174.
76. Ali AT, 2014, Reproductive factors and the risk of
endometrial cancer. Int J Gynecol Cancer, 24(3): 384–393. https://doi.org/10.1155/2012/789174
https://doi.org/10.1097/IGC.0000000000000075 88. Grivennikov SI, Greten FR, Karin M, 2010, Immunity,
inflammation, and cancer. Cell J, 140(6): 883–899.
77. Rojas K, Stuckey A, 2016, Breast cancer epidemiology and
risk factors. Clin Obstet Gynecol, 59(4): 651–672. https://doi.org/10.1016/j.cell.2010.01.025
https://doi.org/10.1097/GRF.0000000000000239 89. Zahalka AH, Arnal-Estapé A, Maryanovich M, et al., 2017,
Adrenergic nerves activate an angio-metabolic switch in
78. Pérez-López FR, 2019, Sporadic ovarian and fallopian tube
cancer in postmenopausal women. In: Postmenopausal prostate cancer. Science, 358(6361): 321–326.
Diseases and Disorders. Cham: Springer. p79–100. https://doi.org/10.1126/science.aah5072
https://doi.org/10.1007/978-3-030-13936-0_5 90. Hara MR, Kovacs JJ, Whalen EJ, et al., 2011, A stress response
pathway regulates DNA damage through β2-adrenoreceptors
79. Brinton LA, Moghissi KS, Westhoff CL, et al., 2010, Cancer
risk among infertile women with androgen excess or and β-arrestin-1. Nature, 477(7364): 349–353.
menstrual disorders (including polycystic ovary syndrome). https://doi.org/10.1038/nature10368
Fertil Steril, 94(5): 1787–1792.
91. Magnon C, Hall SJ, Lin J, et al., 2013, Autonomic nerve
https://doi.org/10.1016/j.fertnstert.2009.10.012 development contributes to prostate cancer progression.
Science, 341(6142): 1236361.
80. Bray F, Ferlay J, Soerjomataram I, et al., 2018, Global cancer
statistics 2018: GLOBOCAN estimates of incidence and https://doi.org/10.1126/science.1236361
mortality worldwide for 36 cancers in 185 countries. CA 92. Papaioannou S, Tzafettas J, 2010, Anovulation with or
Cancer J Clin, 68(6): 394–424.
without PCO, hyperandrogenaemia and hyperinsulinaemia
https://doi.org/10.3322/caac.21492 as promoters of endometrial and breast cancer. Best Pract
Res Clin Obstet Gynaecol, 24(1): 19–27.
81. Xu H, Han Y, Lou J, et al., 2017, PDGFRA, HSD17B4 and
HMGB2 are potential therapeutic targets in polycystic ovarian https://doi.org/10.1016/j.bpobgyn.2008.11.010

Volume 2 Issue 1 (2023) 11 https://doi.org/10.36922/td.328